ProPhase Labs stockholders approval all proposals at Special Meeting

ProPhase Labs (PRPH) announced that stockholders delivered a strong mandate at the Company’s September 9, 2025 Special Meeting, approving all proposals on the agenda. With each proposal receiving more than 75% support, ProPhase received clear authorization to move forward with its strategic initiatives, including a significant increase in authorized shares to 1 billion. “This strong mandate to increase the authorized shares gives us the resources to pursue strategic opportunities and innovative initiatives. In particular, this was an important next step in order to advance a potential crypto treasury strategy to enhance stockholder value and diversify our balance sheet as well as to develop and grow the Company’s current subsidiaries,” said Ted Karkus, Chief Executive Officer and Chairman of ProPhase Labs. “We are very pleased with the overwhelming support from our stockholders for each of these important initiatives.”